“Noubar B. Afeyan, Ph.D.”

a.k.a.:  “Noubar B Afeyan Ph. D.”,  “Noubar B. Afeyan Ph.D.”,  “Noubar B. Afeyan, Ph. D.”,  “Noubar B. Afeyan, Ph.D”

As a Name:  Registrant, Group Member and/or Signatory

        

Latest Filing:  2/23/24  as  ↓Signatory

        

As:  Group Member  (Co-Filer Non-Registrant:  Partner, Affiliate, etc.)

“Noubar B. Afeyan, Ph.D.” has been a Group Member with  9  Filers:

        

As Of	Filer			Filings       #        Latest		Issuer     (Primary)
2/14/24		MA	Flagship Ventures Fund V, L.P.	17	SC 13G/A	MA	Sigilon Therapeutics, Inc.
2/14/23		MA	Flagship VentureLabs IV, LLC	9	SC 13G/A	MA	Rubius Therapeutics, Inc.
2/14/22		MA	Flagship Ventures Fund IV General Partner LLC	9	SC 13G/A	MA	Moderna, Inc.
2/13/20		MA	Flagship Ventures Fund 2004 LP	7	SC 13G/A	MA	Quanterix Corp.
2/14/18		MA	Flagship Ventures Fund IV, L.P.	2	SC 13G/A	MA	Editas Medicine, Inc.
4/7/17		MA	Flagship Ventures Fund 2007, L.P.	16	SC 13D/A	PA	Carisma Therapeutics Inc.
8/3/15		MA	Agtc Advisors Fund LP	5	SC 13D/A	MA	BG Medicine, Inc.
2/12/15		MA	Applied Genomic Technology Capital Fund LP	2	SC 13G/A	MA	Acceleron Pharma Inc.
12/19/14		MA	Newcogen Group LLC	3	SC 13D/A	MA	BG Medicine, Inc.

“Noubar B. Afeyan, Ph.D.” has/had a Group Member interest in  22  Issuers:

As Of	Issuer			Filings       #        Latest		With Filer     (Primary)
2/14/24		MA	Sigilon Therapeutics, Inc.	2	SC 13G/A	MA	Flagship Ventures Fund V, L.P.
2/14/24		WA	Sana Biotechnology, Inc.	2	SC 13G/A	MA	Flagship Ventures Fund V, L.P.
7/13/23		MA	Evelo Biosciences, Inc.	5	SC 13D/A	MA	Flagship Ventures Fund V, L.P.
2/14/23		MA	Codiak BioSciences, Inc.	2	SC 13G/A	MA	Flagship Ventures Fund V, L.P.
2/14/23		MA	Rubius Therapeutics, Inc.	4	SC 13G/A	MA	Flagship VentureLabs IV, LLC
10/17/22		MA	Axcella Health Inc.	5	SC 13D/A	MA	Flagship VentureLabs IV, LLC
7/7/22		MA	Seres Therapeutics, Inc.	5	SC 13D/A	MA	Flagship VentureLabs IV, LLC
2/14/22		MA	Moderna, Inc.	4	SC 13G/A	MA	Flagship Ventures Fund IV General Partner LLC
2/16/21		CA	Denali Therapeutics Inc.	3	SC 13G/A	MA	Flagship Ventures Fund V, L.P.
2/10/21		MA	Kaleido Biosciences, Inc.	3	SC 13D/A	MA	Flagship Ventures Fund V, L.P.
2/13/20		MA	Quanterix Corp.	2	SC 13G/A	MA	Flagship Ventures Fund 2004 LP
2/14/18		MA	Editas Medicine, Inc.	2	SC 13G/A	MA	Flagship Ventures Fund IV, L.P.
2/14/18		MA	T2 Biosystems, Inc.	3	SC 13G/A	MA	Flagship Ventures Fund 2004 LP
8/21/17		MA	Syros Pharmaceuticals, Inc.	2	SC 13D/A	MA	Flagship Ventures Fund IV General Partner LLC
4/7/17		PA	Carisma Therapeutics Inc.	6	SC 13D/A	MA	Flagship Ventures Fund 2007, L.P.
2/13/17		MA	Dnib Unwind, Inc.	2	SC 13G/A	MA	Flagship Ventures Fund 2004 LP
2/13/17		MA	Agios Pharmaceuticals, Inc.	3	SC 13G/A	MA	Flagship Ventures Fund 2007, L.P.
8/3/15		MA	BG Medicine, Inc.	5	SC 13D/A	MA	Agtc Advisors Fund LP
2/12/15		MA	Acceleron Pharma Inc.	2	SC 13G/A	MA	Applied Genomic Technology Capital Fund LP
2/20/14		MA	Tetraphase Pharmaceuticals Inc.	3	SC 13D/A	MA	Flagship Ventures Fund 2007, L.P.
			More...  Please Sign In to list all 22 of them.

“Noubar B. Afeyan, Ph.D.” has been a Group Member with  52  other Group Members:

As Of	Group Member			Filings       #        Latest		With Filer     (Primary)		Issuer     (Primary)
2/14/24		MA	Flagship Pioneering Special Opportunities Fd II Gen’l P..LLC	2	SC 13G/A	MA	Flagship Ventures Fund V, L.P.	MA	Sigilon Therapeutics, Inc.
		MA	Flagship Pioneering Special Opportunities Fund II, L.P.	2
		MA	Flagship Pioneering, Inc.	21
		MA	Flagship Ventures Fund V General Partner LLC	18
2/14/24		MA	Flagship Pioneering Fund VI General Partner LLC	5	SC 13G/A	MA	Flagship Ventures Fund V, L.P.	WA	Sana Biotechnology, Inc.
		MA	Flagship Pioneering Fund VI, L.P.	5
		MA	Flagship V Venturelabs RX Fund, L.P.	11
		MA	Flagship Venturelabs V, LLC	10
		MA	Venturelabs V Manager LLC	2
7/13/23		MA	Flagship Pioneering Fund VII General Partner LLC	3	SC 13D/A	MA	Flagship Ventures Fund V, L.P.	MA	Evelo Biosciences, Inc.
		MA	Flagship Pioneering Fund VII, L.P.	3
		MA	Flagship Venturelabs IV, LLC	18
		MA	Flagship Venturelabs V Manager LLC	9
		MA	Flagship Ventures Fund IV General Partner LLC	30
		MA	Flagship Ventures Fund IV, L.P.	37
		MA	Flagship Ventures Fund IV – RX, L.P.	33
		MA	Flagship Ventures Opportunities Fund I General Partner LLC	17
		MA	Flagship Ventures Opportunities Fund I, L.P.	17
		MA	Nutritional Health Disruptive Innovation Fund, L.P.	8
		MA	Nutritional Health LTP Fund, L.P.	9
			More...  Please Sign In to list all 52 of them.

As:  Signatory  (Director, Officer, Attorney, Accountant, Banker, Agent, etc.)

“Noubar B. Afeyan, Ph.D.” has been a Signatory for/with  8  Filers:

        

As Of	Filer			Filings       #        Latest		Issuer     (Primary)
2/23/24		MA	Moderna, Inc.	4	10-K	—
2/14/24		MA	Flagship Ventures Fund V, L.P.	14	SC 13G/A	MA	Sigilon Therapeutics, Inc.
2/14/23		MA	Flagship VentureLabs IV, LLC	6	SC 13G/A	MA	Rubius Therapeutics, Inc.
2/14/22		MA	Flagship Ventures Fund IV General Partner LLC	4	SC 13G/A	MA	Moderna, Inc.
8/2/21		MA	Omega Therapeutics, Inc.	2	S-8	—
1/12/21		WA	Sana Biotechnology, Inc.	1	S-1	—
10/19/20		MA	Foghorn Therapeutics Inc.	3	S-1/A	—
7/31/07		MA	Afeyan Noubar	1	4	MA	Helicos Biosciences Corp.

“Noubar B. Afeyan, Ph.D.” has/had a Signatory interest in  13  Issuers:

As Of	Issuer			Filings       #        Latest		With Filer     (Primary)
2/14/24		MA	Sigilon Therapeutics, Inc.	2	SC 13G/A	MA	Flagship Ventures Fund V, L.P.
2/14/24		WA	Sana Biotechnology, Inc.	2	SC 13G/A	MA	Flagship Ventures Fund V, L.P.
7/13/23		MA	Evelo Biosciences, Inc.	3	SC 13D/A	MA	Flagship Ventures Fund V, L.P.
2/27/23		MA	Omega Therapeutics, Inc.	2	SC 13D/A	MA	Flagship Ventures Fund V, L.P.
2/14/23		MA	Codiak BioSciences, Inc.	2	SC 13G/A	MA	Flagship Ventures Fund V, L.P.
2/14/23		MA	Rubius Therapeutics, Inc.	3	SC 13G/A	MA	Flagship VentureLabs IV, LLC
10/17/22		MA	Axcella Health Inc.	3	SC 13D/A	MA	Flagship VentureLabs IV, LLC
7/7/22		MA	Seres Therapeutics, Inc.	2	SC 13D/A	MA	Flagship VentureLabs IV, LLC
2/14/22		MA	Moderna, Inc.	2	SC 13G/A	MA	Flagship Ventures Fund IV General Partner LLC
2/16/21		CA	Denali Therapeutics Inc.	1	SC 13G/A	MA	Flagship Ventures Fund V, L.P.
2/10/21		MA	Kaleido Biosciences, Inc.	1	SC 13D/A	MA	Flagship Ventures Fund V, L.P.
10/29/20		MA	Foghorn Therapeutics Inc.	1	SC 13D	MA	Flagship Ventures Fund V, L.P.
7/31/07		MA	Helicos Biosciences Corp.	1	4	MA	Afeyan Noubar